Lumexa Imaging Announces Third Quarter 2026 Earnings Conference Call Date
Lumexa Imaging Holdings, Inc. has scheduled the release of its third quarter 2026 financial and operational results for November 10, 2026.
Stocks · News reference
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Raises Price Target to $13
Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and raises the price target from $9 to $13.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
This Vertiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Analysts initiated bullish coverage on VRT, VYLR, ATHR, LMRI and NVT, assigning Buy or Outperform ratings and price targets.
Truist Securities Initiates Coverage On Lumexa Imaging Hldgs with Buy Rating, Announces Price Target of $18
Truist Securities analyst Clarke Murphy initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Buy rating and announces Price Target of $18.
Keybanc Initiates Coverage On Lumexa Imaging Hldgs with Overweight Rating, Announces Price Target of $18
Keybanc analyst Matthew Gillmor initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight rating and announces Price Target of $18.